Precision BioSciences, Inc. (NASDAQ:DTIL – Get Rating) – Research analysts at William Blair cut their Q3 2023 EPS estimates for shares of Precision BioSciences in a note issued to investors on Monday, June 8th. William Blair analyst R. Prasad now anticipates that the company will post earnings of ($0.48) per share for the quarter, down from their prior forecast of ($0.45). William Blair has a ‘Market Perform’ rating on the stock. The consensus estimate for Precision BioSciences’ current full-year earnings is ($1.
